About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
MF HOLDINGS
MF
Holdings
Mankind Pharma Ltd.
BSE Code
543904
ISIN Demat
INE634S01028
Book Value
344.33
NSE Code
MANKIND
Dividend Yield %
0.00
Market Cap
1065545.93
P/E
54.44
EPS
47.44
Face Value
1
Scheme Name
Market Val (In Crs.)
AUM(In Crs.)
Hold Percentage
SBI BlueChip Fund-Reg(G)
680.64
49394.17
1.38
HDFC Large Cap Fund(G)
445.72
36108.73
1.23
Axis ELSS Tax Saver Fund-Reg(G)
322.71
34176.5
0.94
SBI Contra Fund-Reg(IDCW)
322.02
42220.04
0.76
SBI Magnum Midcap Fund-Reg(G)
306.94
20890.26
1.47
Invesco India Contra Fund(G)
267.47
17265.19
1.55
Axis Flexi Cap Fund-Reg(G)
261.00
12039.75
2.17
PGIM India Midcap Opp Fund-Reg(G)
223.81
10302.07
2.17
Motilal Oswal Midcap Fund-Reg(G)
222.73
26028.34
0.86
Canara Rob Bluechip Equity Fund-Reg(G)
218.68
14965.25
1.46
Kotak Small Cap Fund(G)
192.94
15706.46
1.23
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
171.92
4914.64
3.50
Axis Bluechip Fund-Reg(G)
166.21
32349.42
0.51
Canara Rob Flexi Cap Fund-Reg(G)
165.25
12194.01
1.36
Nippon India Pharma Fund(G)
157.38
8080.97
1.95
Invesco India Focused Fund-Reg(G)
136.93
3532.65
3.88
SBI Healthcare Opp Fund-Reg(IDCW)
135.79
3610.51
3.76
SBI Large & Midcap Fund-Reg(IDCW)
130.28
29416.39
0.44
Nippon India ELSS Tax Saver Fund(G)
128.49
14392.25
0.89
Nippon India Flexi Cap Fund-Reg(G)
128.12
8250.3
1.55
Page
1
of
8
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.